… Herein, we summarize the latest advances in Ti-EVs for cancers and non-cancer diseases.
… isolation and characterization between cancers and non-cancer diseases are reviewed and …

… We propose that neurodegenerative diseases and cancer share a common route of transport
of disease-related proteins and nucleic acids that could mirror normal neurocytological …

… shift whereby cancer is now considered more than a disease defined by molecular (genetic
and epigenetic) events within a cell and is also considered an ‘ecological disease’ that is …

… Cancer-derived extracellular vesicles (EVs) are regarded as having promising potential to
be used as therapeutics and disease biomarkers. Mechanistically, EVs have been shown to …

… the roles of EVs in the pathology of various diseases such as cancer, neurodegenerative
diseases and cardiovascular disease 22 . The pathological capability of EVs is acquired from …

… release small vesicles known as extracellular vesicles (EVs) into the extracellular milieu. EVs
… in the field of clinical application of EVs in various diseases such as cancers. In the case of …

… 9.8 million cancer-related deaths were reported worldwide. In the last 20 years, it has become
apparent that small vesicles released by cancer cells, referred to as extracellular vesicles (…

… The past decade has witnessed a rapid growth of research and technology development
related to extracellular vesicles (EVs). Secretion of EVs is a fundamental and evolutionarily …

… Introduction – cooperation versus competition in the ‘world’ of cancer cells Cancer is
generally viewed as a disease of mutant genes 1, 2. This is often taken to imply that oncogenic …

… The same pattern of pathological mineral initiation by extracellular plasma membrane-… ,
calcifying extracellular vesicles are derived not only from exfoliated surface vesicles but also from …